patent
Drug Combination for Treatment of Proliferative Diseases
2017
Angiogenesis inhibitory drug combination obtained according to a specific algorithm, preferably a FSC, in which an initial combination of drugs is iteratively adjusted. The drug combination according to the invention may advantageously comprise a RAPTA-C compound. In a more specific case the combination comprises RAPTA-C and eriotinib.
Type
patent
EPO Family ID
52875103
Author(s)
Dyson, Paul
Griffioen, Arjan
Weiss, Andrea
Van Den Bergh, Hubert
Ding, Xianting
Note
Alternative title(s) : (de) Arzneimittelkombination zur behandlung proliferativer krankheiten (fr) Association de médicaments pour le traitement de maladies prolifératives (en) Drug combination for treatment of proliferative diseases
TTO classification
TTO:6.1380
| Identifier | Country code | Kind code | Date issued |
US2017014372 | US | A1 | 2017-01-19 |
EP3116485 | EP | A2 | 2017-01-18 |
WO2015136061 | WO | A3 | 2016-01-21 |
WO2015136061 | WO | A2 | 2015-09-17 |
Available on Infoscience
May 2, 2017
Use this identifier to reference this record